Jim Cramer: Buy FedEx, Grana Y Montero, and Hexcel, But Sell These 2 Stocks

Jim Cramer made the following calls on September 13th, 2013. What do you think about his picks?

FedEx Corporation (NYSE:FDX): Jim Cramer ranked this stock a Buy. Cramer previously ranked this stock a Buy on November 26, 2012. The stock’s 52-week high is $113.34, and its 52-week low is $83.92. FedEx is set to report earnings on Wednesday, an event that could have a significant impact on the stock’s price. The EPS for the company is expected to be $1.52, while revenues for the first fiscal quarter are expected by be around $11 billion. Cramer still rates the stock a buy at this point in time, thinking that Wednesday’s news may be a positive for the company.

FDX-20130916

Grana Y Montero (NYSE:GRAM): Jim Cramer ranked this stock a Buy. The stock’s 52-week high is $21.94, and its 52-week low is $18.74. The Peruvian construction giant has only been on the New York Stock Exchange for a couple months, and it has already gone through a dip and then a surge as well as an issuance of a second round of common stock. Cramer said that he was warming up to the company now that it has been on the exchange for a little while.

GRAM-20130916

Hexcel Corp. (NYSE:HXL): Jim Cramer ranked this stock a Buy. Cramer previously ranked this stock a Buy on August 20, 2012. The stock’s 52-week high is $37.88, and its 52-week low is $23.23. Cramer used the phrase “really fine” to refer to Hexcel, a producer of materials such as resins, adhesives, and fibers. Earlier this month, Hexcel entered into a deal with Level 3 Communications (NASDAQ:LVLT) so that the company can improve its networking on a global scale.

HXL-20130916

1-800-Flowers.com Inc. (NASDAQ:FLWS): Jim Cramer ranked this stock a Sell. The stock’s 52-week high is $7.17, and its 52-week low is $2.77. After peaking near the beginning of August, Cramer now thinks that the stock is fairly valued, and he does not look for it to be on the rise again. The company recently announced a deal with AARP in order to provide lower prices on flowers for customers who are members of the organization.

FLWS-20130916

Immunomedics Inc. (NASDAQ:IMMU): Jim Cramer ranked this stock a Sell. Cramer previously ranked this stock a Sell on August 15, 2013. The stock’s 52-week high is $6.91, and its 52-week low is $2.11. Immunomedics had a fanfastic summer, with the stock more than doubling in value between May and August of this year. However, Cramer thinks that the boat has sailed on the company, ranking it a sell once more.

IMMMU-20130916

Don’t Miss: Will GM’s New Deal Settle Labor Issues in Canada?

More from The Cheat Sheet